Healthcare and Medical Imaging

This study offers an in-depth analysis of the performance of 11 different manufacturers with a deep dive into how a variety of touch points across the customer journey shapes customer experience scores. We asked 300 diagnostic imaging professionals to evaluate their experiences during specific touchpoints with OEMs, such as product awareness, selection, service, and support.…

IMV’s 2025 Neurology in Diagnostic Imaging Market Outlook Report explores neurology-related imaging market factors across CT, MRI, PET, SPECT, C-Arm, X-Ray and Ultrasound systems. The report examines aspects of market trends, procedure volume, installed base, equipment purchase plans, contrast utilization/budgets, and site operations characteristics. Survey results are projected to the identified universe of neurology-related imaging…

IMV’s 2023 Oncology in Diagnostic Imaging Market Outlook Report explores oncology-related imaging market factors across CT, MRI, PET, SPECT, C-Arm, Mammography, X-Ray and Ultrasound systems. The report examines aspects of market trends, procedure volume, installed base, equipment purchase plans, contrast utilization/budgets, trends, and site operations characteristics. Survey results are projected to the identified universe of…

Artificial intelligence (AI) is influencing healthcare in countless ways, and its impact on diagnostic imaging is one of the greatest. This is due to the dependence on visual examination, demand for increased procedures, more data analysis required per scan, error/cost reduction, and the development of specific computing tools that make AI-guided decisions far more practical.

…

Over the past decade, the ultrasound industry has experienced a dynamic transformation in the equipment capabilities that healthcare providers can use. The features available on conventional cart-based units have become increasingly sophisticated while the availability of even more portable laptop/tablet and handheld units have enabled their use in point-of-care and other locations inside and outside…

IMV’s 2024 Nuclear Medicine Market Outlook examines nuclear medicine procedure volumes, purchase plans, and buying criteria for future nuclear medicine purchases. Learn how NM administrators feel about their department’s future outlook and how they prioritize their goals in light of industry challenges. The report explores nuclear medicine market trends, including NM procedure volume, installed base…

This 2025 Mammography and Breast Imaging Market Outlook Report summarizes the results of IMV Medical Information Division’s 2025 survey of U.S. hospitals and independent imaging centers that perform mammography procedures using mammography scanners and provides a summary of the mammography and breast imaging medical imaging market. The report provides detailed information about the priorities and…

PET imaging has grown over the past two decades to become a mainstay in the diagnosis and management of cancer patients. While oncology scans continue to comprise the majority of PET scans, new radiopharmaceuticals offer the promise of increasing the efficacy of PET imaging for cardiology and neurology.

IMV’s 2025 PET Imaging Market Summary Report…

Molecular point-of-care (mPOC) diagnostics are revolutionizing the in vitro diagnostics (IVD) landscape, delivering the sensitivity and specificity of molecular testing with the accessibility and speed of traditional point-of-care (POC) solutions. Kalorama Information’s latest report, Molecular Point-of-Care (mPOC) Market Outlook and Innovations, 2024-2029, provides a comprehensive analysis of this rapidly evolving market, covering the size, growth trajectory,…

Kalorama Information’s The World Market for HbA1c Testing: Trends, Technologies, and Growth Opportunities, 2025 provides a comprehensive analysis of the global HbA1c testing market, highlighting key trends, technological advancements, and growth opportunities. This report delves into the geographical distribution, demographic influences, and critical market issues shaping the industry. It offers a detailed examination of market values, regional…

The landscape of cancer diagnostics is evolving with molecular and protein biomarkers indispensable for accurate diagnosis, therapy selection, monitoring treatment response, and early detection of cancer recurrence. Kalorama Information’s The World Market for Cancer Diagnostics, 2024-2029 delivers an authoritative and comprehensive analysis of the global cancer in vitro diagnostics (IVD) market, including industry-defining trends, market…

With over two decades of experience in publishing in vitro diagnostic (IVD) market research, Kalorama Information presents the 30 Country In Vitro Diagnostics (IVD) Market Atlas, 2024. This quarterly updated report offers a unique approach focused on country-level research and analysis, providing a detailed analysis of major IVD segments forecasted for five years…